Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07234903 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury

Study acronym: EIGER
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date: Jan 2026 to Apr 2026
    • Primary and study completion dates: Jan 2032 to Apr 2032
    • Site details revised at 2 of 2 sites
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The EIGER study aims to evaluate the safety and preliminary efficacy of ARC-IM Therapy (Epidural Electrical Stimulation) to support and promote recovery of ambulatory functions, such as walking, in people with subacute and chronic spinal cord injury.
Trial Details
NCT Number NCT07234903
Lead Sponsor Ecole Polytechnique Fédérale de Lausanne
Conditions
(from sponsor)		 Spinal Cord Injury, SCI, SCI - Spinal Cord Injury, Subacute Spinal Cord Injury, Chronic Spinal Cord Injury, Spinal Cord Injury (SCI)
Related terms Spinal Cord Injuries
Enrollment 12 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov